Безопасен ли jasminum officinale flower/leaf extract при беременности?
No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
Pregnancy-safe products containing jasminum officinale flower/leaf extract










Related ingredients
Frequently asked questions
- Безопасен ли jasminum officinale flower/leaf extract при беременности?
- No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
- Безопасен ли jasminum officinale flower/leaf extract при грудном вскармливании?
- No evidence of reproductive/ developmental toxicity or lactation transfer reported in SCCS/CIR or peer‑reviewed literature for this extract. Systemic absorption from typical topical cosmetic use is low but measurable, so breastfeeding exposure is scored as low (1). Sources: CIR (no specific restriction), CosIng, PubChem.
- Безопасен ли jasminum officinale flower/leaf extract для кожи малыша?
- No infant‑specific reproductive or developmental hazards identified. Mechanistic data lacking. Because infants (0–3 yr) have higher dermal absorption and surface‑area‑to‑weight ratio, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Note: this does not indicate intrinsic reproductive hazard but reflects higher potential exposure through immature skin. Sources: CosIng, PubChem, general toxicological principles on infant skin permeability.
- Как VeriMom оценивает jasminum officinale flower/leaf extract?
- VeriMom оценивает jasminum officinale flower/leaf extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы jasminum officinale flower/leaf extract при беременности?
- См. наш список безопасных альтернатив jasminum officinale flower/leaf extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.